{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:45:35Z","timestamp":1792633535298,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11060-023-04352-0","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T05:04:58Z","timestamp":1685423098000},"page":"355-365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Safety and efficacy of Cesium-131 brachytherapy for brain tumors"],"prefix":"10.1007","volume":"163","author":[{"given":"Evan D.","family":"Bander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Christos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Gabriella","family":"Wernicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Stieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Trichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.S.","family":"Knisely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore H.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"4352_CR1","doi-asserted-by":"publisher","unstructured":"Patchell RA, Tibbs PA, Regine WF et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280(17). https:\/\/doi.org\/10.1001\/jama.280.17.1485","DOI":"10.1001\/jama.280.17.1485"},{"key":"4352_CR2","doi-asserted-by":"publisher","unstructured":"Mahajan A, Ahmed S, McAleer MF et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8). https:\/\/doi.org\/10.1016\/S1470-2045(17)30414-X","DOI":"10.1016\/S1470-2045(17)30414-X"},{"key":"4352_CR3","doi-asserted-by":"publisher","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352(10). https:\/\/doi.org\/10.1056\/nejmoa043330","DOI":"10.1056\/nejmoa043330"},{"key":"4352_CR4","doi-asserted-by":"publisher","unstructured":"Bander ED, Yuan M, Reiner AS et al (2021) Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control. Neuro-Oncology Pract 8(3). https:\/\/doi.org\/10.1093\/nop\/npab005","DOI":"10.1093\/nop\/npab005"},{"key":"4352_CR5","doi-asserted-by":"publisher","unstructured":"Roth O\u2019Brien DA, Poppas P, Kaye SM et al (2021) Timing of adjuvant fractionated stereotactic Radiosurgery affects local control of Resected Brain Metastases. Pract Radiat Oncol 11(3). https:\/\/doi.org\/10.1016\/j.prro.2021.01.011","DOI":"10.1016\/j.prro.2021.01.011"},{"key":"4352_CR6","doi-asserted-by":"publisher","unstructured":"Mahase SS, Navrazhina K, Schwartz TH, Parashar B, Wernicke AG (2019) Intraoperative brachytherapy for resected brain metastases. Brachytherapy 18(3). https:\/\/doi.org\/10.1016\/j.brachy.2019.01.011","DOI":"10.1016\/j.brachy.2019.01.011"},{"key":"4352_CR7","doi-asserted-by":"publisher","unstructured":"Wernicke AG, Taube S, Smith AW, Parashar B (2017) Central Nervous System Brachytherapy. In: Handbook of Image-Guided Brachytherapy.; https:\/\/doi.org\/10.1007\/978-3-319-44827-5_18","DOI":"10.1007\/978-3-319-44827-5_18"},{"key":"4352_CR8","doi-asserted-by":"publisher","unstructured":"Ostertag CB, Kreth FW (1995) Interstitial iodine-125 radiosurgery for cerebral metastases. Br J Neurosurg 9(5). https:\/\/doi.org\/10.1080\/02688699550040873","DOI":"10.1080\/02688699550040873"},{"key":"4352_CR9","doi-asserted-by":"crossref","unstructured":"Prados M, Leibel S, Barnett CM, Gutin P (1989) Interstitial brachytherapy for metastatic brain tumors. Cancer 63(4). https:\/\/doi.org\/10.1002\/1097-0142(19890215)63:4<657::AID-CNCR2820630410>3.0.CO;2-Q","DOI":"10.1002\/1097-0142(19890215)63:4<657::AID-CNCR2820630410>3.0.CO;2-Q"},{"key":"4352_CR10","doi-asserted-by":"publisher","unstructured":"Laperriere NJ, Leung PMK, McKenzie S et al (1998) Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41(5). https:\/\/doi.org\/10.1016\/S0360-3016(98)00159-X","DOI":"10.1016\/S0360-3016(98)00159-X"},{"key":"4352_CR11","doi-asserted-by":"publisher","unstructured":"Selker RG, Shapiro WR, Burger P et al (2002) The Brain Tumor Cooperative Group NIH Trial 87 \u2013 01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51(2). https:\/\/doi.org\/10.1097\/00006123-200208000-00009","DOI":"10.1097\/00006123-200208000-00009"},{"key":"4352_CR12","doi-asserted-by":"publisher","unstructured":"Charfen CO, Sneed PK, Wara WM et al (1992) High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 24(4). https:\/\/doi.org\/10.1016\/0360-3016(92)90702-J","DOI":"10.1016\/0360-3016(92)90702-J"},{"key":"4352_CR13","doi-asserted-by":"publisher","unstructured":"Gutin PH, Prados MD, Phillips TL et al (1991) External irradiation followed by an interstitial high activity iodine-125 implant \u201cboost\u201d in the initial treatment of malignant gliomas: NCOG study 6G-82-2 gliomas: NCOG study 6H-82-2. Int J Radiat Oncol Biol Phys 21(3). https:\/\/doi.org\/10.1016\/0360-3016(91)90676-U","DOI":"10.1016\/0360-3016(91)90676-U"},{"key":"4352_CR14","doi-asserted-by":"publisher","unstructured":"Dagnew E, Kanski J, McDermott MW et al (2007) Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience. Neurosurg Focus 22(3). https:\/\/doi.org\/10.3171\/foc.2007.22.3.4","DOI":"10.3171\/foc.2007.22.3.4"},{"key":"4352_CR15","doi-asserted-by":"publisher","unstructured":"Raleigh DR, Seymour ZA, Tomlin B et al (2017) Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis. J Neurosurg 126(6). https:\/\/doi.org\/10.3171\/2016.4.JNS152530","DOI":"10.3171\/2016.4.JNS152530"},{"key":"4352_CR16","doi-asserted-by":"publisher","unstructured":"Magill ST, Lau D, Raleigh DR, Sneed PK, Fogh SE, McDermott MW (2017) Surgical resection and interstitial iodine-125 brachytherapy for high-grade meningiomas: a 25-year series. Neurosurgery 80(3). https:\/\/doi.org\/10.1227\/NEU.0000000000001262","DOI":"10.1227\/NEU.0000000000001262"},{"key":"4352_CR17","doi-asserted-by":"publisher","unstructured":"Huang K, Sneed PK, Kunwar S et al (2009) Surgical resection and permanent iodine-125 brachytherapy for brain metastases. J Neurooncol 91(1). https:\/\/doi.org\/10.1007\/s11060-008-9686-2","DOI":"10.1007\/s11060-008-9686-2"},{"key":"4352_CR18","doi-asserted-by":"publisher","unstructured":"Yondorf MZ, Faraz S, Smith AW et al (2020) Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases. J Contemp Brachytherapy 12(4). https:\/\/doi.org\/10.5114\/jcb.2020.98109","DOI":"10.5114\/jcb.2020.98109"},{"key":"4352_CR19","doi-asserted-by":"publisher","unstructured":"Han DY, Ma L, Braunstein S, Raleigh D, Sneed PK, McDermott M Resection Cavity Contraction Effects in the Use of Radioactive Sources (1\u201325 versus Cs-131) for Intra-Operative Brain Implants. Cureus. Published online 2018. https:\/\/doi.org\/10.7759\/cureus.2079","DOI":"10.7759\/cureus.2079"},{"key":"4352_CR20","doi-asserted-by":"publisher","unstructured":"Julie DA, Lazow SP, Vanderbilt DB et al (2021) A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases. J Neurosurg 134(5). https:\/\/doi.org\/10.3171\/2020.3.JNS193419","DOI":"10.3171\/2020.3.JNS193419"},{"key":"4352_CR21","doi-asserted-by":"publisher","unstructured":"Pham A, Yondorf MZ, Parashar B et al (2016) Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial. J Neurooncol 127(1). https:\/\/doi.org\/10.1007\/s11060-015-2009-5","DOI":"10.1007\/s11060-015-2009-5"},{"key":"4352_CR22","doi-asserted-by":"publisher","unstructured":"Wernicke AG, Yondorf MZ, Peng L et al (2014) Phase I\/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases. J Neurosurg 121(2). https:\/\/doi.org\/10.3171\/2014.3.JNS131140","DOI":"10.3171\/2014.3.JNS131140"},{"key":"4352_CR23","doi-asserted-by":"publisher","unstructured":"Wernicke AG, Smith AW, Taube S et al (2017) Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease. J Neurosurg 126(4). https:\/\/doi.org\/10.3171\/2016.3.JNS152836","DOI":"10.3171\/2016.3.JNS152836"},{"key":"4352_CR24","doi-asserted-by":"publisher","unstructured":"Wernicke AG, Taube S, Smith AW, Herskovic A, Parashar B, Schwartz TH (2020) Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control. Brachytherapy 19(5). https:\/\/doi.org\/10.1016\/j.brachy.2020.06.013","DOI":"10.1016\/j.brachy.2020.06.013"},{"key":"4352_CR25","doi-asserted-by":"publisher","unstructured":"Wernicke AG, Hirschfeld CB, Smith AW et al (2017) Clinical outcomes of large brain metastases treated with neurosurgical resection and intraoperative Cesium-131 brachytherapy: results of a prospective trial. Int J Radiat Oncol Biol Phys 98(5). https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.044","DOI":"10.1016\/j.ijrobp.2017.03.044"},{"key":"4352_CR26","doi-asserted-by":"publisher","unstructured":"Wernicke AG, Lazow SP, Taube S et al (2016) Surgical technique and clinically relevant resection cavity dynamics following implantation of cesium-131 brachytherapy in patients with brain metastases. Oper Neurosurg 12(4). https:\/\/doi.org\/10.1227\/NEU.0000000000000986","DOI":"10.1227\/NEU.0000000000000986"},{"key":"4352_CR27","doi-asserted-by":"publisher","unstructured":"Chen WC, Lafreniere M, Phuong C et al Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors. J Neurosurg. Published online 2022. https:\/\/doi.org\/10.3171\/2021.10.jns211886","DOI":"10.3171\/2021.10.jns211886"},{"key":"4352_CR28","doi-asserted-by":"crossref","unstructured":"Imber, BS YRBKRAG-LAKSYJA-NDCGBCTVMN (2022). Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases. J Neurooncol. ;159(3)","DOI":"10.1007\/s11060-022-04101-9"},{"key":"4352_CR29","doi-asserted-by":"publisher","unstructured":"Gessler DJ, Ferreira C, Dusenbery K, Chen CC, GammaTile\u00ae (2020) Surgically targeted radiation therapy for glioblastomas. Futur Oncol 16(30). https:\/\/doi.org\/10.2217\/fon-2020-0558","DOI":"10.2217\/fon-2020-0558"},{"key":"4352_CR30","doi-asserted-by":"publisher","unstructured":"Mooney MA, Bi WL, Cantalino JM et al (2020) Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. J Neurooncol 146(1). https:\/\/doi.org\/10.1007\/s11060-019-03342-5","DOI":"10.1007\/s11060-019-03342-5"},{"key":"4352_CR31","doi-asserted-by":"publisher","unstructured":"Palmisciano P, Haider AS, Balasubramanian K, D\u2019Amico RS, Wernicke AG (2022) The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials. J Neurooncol 159(1). https:\/\/doi.org\/10.1007\/s11060-022-04050-3","DOI":"10.1007\/s11060-022-04050-3"},{"key":"4352_CR32","doi-asserted-by":"publisher","unstructured":"Brennan C, Yang TJ, Hilden P et al (2014) A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys 88(1). https:\/\/doi.org\/10.1016\/j.ijrobp.2013.09.051","DOI":"10.1016\/j.ijrobp.2013.09.051"},{"key":"4352_CR33","doi-asserted-by":"publisher","unstructured":"Mengue L, Bertaut A, Ngo Mbus L et al (2020) Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation. Radiat Oncol 15(1). https:\/\/doi.org\/10.1186\/s13014-020-01517-3","DOI":"10.1186\/s13014-020-01517-3"},{"key":"4352_CR34","doi-asserted-by":"publisher","unstructured":"Mathieu D, Kondziolka D, Flickinger JC et al (2008) Tumor bed radiosurgery after resection of cerebral metastases. Neurosurgery 62(4). https:\/\/doi.org\/10.1227\/01.neu.0000316899.55501.8b","DOI":"10.1227\/01.neu.0000316899.55501.8b"},{"key":"4352_CR35","doi-asserted-by":"publisher","unstructured":"Yusuf MB, Amsbaugh MJ, Burton E et al (2018) Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: investigating clinical outcomes and identifying predictors associated with time to initiation. J Neurooncol 136(3). https:\/\/doi.org\/10.1007\/s11060-017-2679-2","DOI":"10.1007\/s11060-017-2679-2"},{"key":"4352_CR36","doi-asserted-by":"publisher","unstructured":"Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH (2006) Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104(6). https:\/\/doi.org\/10.3171\/jns.2006.104.6.907","DOI":"10.3171\/jns.2006.104.6.907"},{"key":"4352_CR37","doi-asserted-by":"publisher","unstructured":"Petr MJ, McPherson CM, Breneman JC, Warnick RE (2009) Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy. J Neurooncol 92(3 SPEC ISS). https:\/\/doi.org\/10.1007\/s11060-009-9868-6","DOI":"10.1007\/s11060-009-9868-6"},{"key":"4352_CR38","doi-asserted-by":"publisher","unstructured":"Wilcox JA, Brown S, Reiner AS et al (2021) Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation. J Neurooncol 155(3). https:\/\/doi.org\/10.1007\/s11060-021-03872-x","DOI":"10.1007\/s11060-021-03872-x"},{"key":"4352_CR39","doi-asserted-by":"publisher","unstructured":"Sanghvi SM, Lischalk JW, Cai L et al (2017) Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy. Radiat Oncol 12(1). https:\/\/doi.org\/10.1186\/s13014-017-0774-3","DOI":"10.1186\/s13014-017-0774-3"},{"key":"4352_CR40","doi-asserted-by":"publisher","unstructured":"Go PH, Klaassen Z, Meadows MC, Chamberlain RS (2011) Gastrointestinal cancer and brain metastasis. Cancer 117(16). https:\/\/doi.org\/10.1002\/cncr.25940","DOI":"10.1002\/cncr.25940"},{"key":"4352_CR41","doi-asserted-by":"crossref","unstructured":"Farnell GF, Buckner JC, Cascino TL, O\u2019Connell MJ, Schomberg PJ, Suman V (1996) Brain metastases from colorectal carcinoma: the long term survivors. Cancer 78(4). https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19960815)78:4<711::AID-CNCR3>3.0.CO;2-H","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<711::AID-CNCR3>3.0.CO;2-H"},{"key":"4352_CR42","doi-asserted-by":"publisher","unstructured":"Goldman DA, Hovinga K, Reiner AS, Esquenazi Y, Tabar V, Panageas KS (2018) The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis. J Neurosurg 129(5). https:\/\/doi.org\/10.3171\/2017.6.JNS17393","DOI":"10.3171\/2017.6.JNS17393"},{"key":"4352_CR43","doi-asserted-by":"publisher","unstructured":"Botros D, Dux H, Price C, Khalafallah AM, Mukherjee D (2021) Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review. Neurosurg Rev 44(3). https:\/\/doi.org\/10.1007\/s10143-020-01331-1","DOI":"10.1007\/s10143-020-01331-1"},{"key":"4352_CR44","doi-asserted-by":"publisher","unstructured":"Bloch O, Han SJ, Cha S et al (2012) Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg 117(6). https:\/\/doi.org\/10.3171\/2012.9.JNS12504","DOI":"10.3171\/2012.9.JNS12504"},{"key":"4352_CR45","doi-asserted-by":"publisher","unstructured":"Gabayan AJ, Green SB, Sanan A et al (2006) GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery 58(4). https:\/\/doi.org\/10.1227\/01.NEU.0000194836.07848.69","DOI":"10.1227\/01.NEU.0000194836.07848.69"},{"key":"4352_CR46","doi-asserted-by":"publisher","unstructured":"Larson DA, Suplica JM, Chang SM et al (2004) Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro Oncol 6(2). https:\/\/doi.org\/10.1215\/S1152851703000425","DOI":"10.1215\/S1152851703000425"},{"key":"4352_CR47","doi-asserted-by":"publisher","unstructured":"Florell RC, Macdonald DR, Irish WD et al (1992) Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76(2). https:\/\/doi.org\/10.3171\/jns.1992.76.2.0179","DOI":"10.3171\/jns.1992.76.2.0179"},{"key":"4352_CR48","doi-asserted-by":"publisher","unstructured":"Koch MJ, Agarwalla PK, Royce TJ et al (2019) Brachytherapy as an adjuvant for recurrent atypical and malignant meningiomas. Clin Neurosurg 85(5). https:\/\/doi.org\/10.1093\/neuros\/nyz115","DOI":"10.1093\/neuros\/nyz115"},{"key":"4352_CR49","doi-asserted-by":"publisher","unstructured":"Brachman D, Youssef E, Dardis C, Smith K, Pinnaduwage D, Nakaji P (2019) Surgically targeted Radiation Therapy: Safety Profile of Collagen Tile Brachytherapy in 79 recurrent, previously irradiated Intracranial Neoplasms on a prospective clinical trial. Brachytherapy 18(3). https:\/\/doi.org\/10.1016\/j.brachy.2019.04.076","DOI":"10.1016\/j.brachy.2019.04.076"},{"key":"4352_CR50","doi-asserted-by":"publisher","unstructured":"Brachman DG, Youssef E, Dardis CJ et al (2019) Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas. J Neurosurg 131(6). https:\/\/doi.org\/10.3171\/2018.7.JNS18656","DOI":"10.3171\/2018.7.JNS18656"},{"key":"4352_CR51","doi-asserted-by":"publisher","unstructured":"Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as a predictor of Brain Radionecrosis after Linear Accelerator Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys 77(4). https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.006","DOI":"10.1016\/j.ijrobp.2009.06.006"},{"key":"4352_CR52","doi-asserted-by":"publisher","unstructured":"Minniti G, Clarke E, Lanzetta G et al (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6(1). https:\/\/doi.org\/10.1186\/1748-717X-6-48","DOI":"10.1186\/1748-717X-6-48"},{"key":"4352_CR53","doi-asserted-by":"publisher","unstructured":"Aoyama H, Shirato H, Onimaru R et al (2003) Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 56(3). https:\/\/doi.org\/10.1016\/S0360-3016(03)00014-2","DOI":"10.1016\/S0360-3016(03)00014-2"},{"key":"4352_CR54","doi-asserted-by":"publisher","unstructured":"Elaimy AL, MacKay AR, Lamoreaux WT et al (2011) Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors. World Neurosurg 75(5\u20136). https:\/\/doi.org\/10.1016\/j.wneu.2010.12.006","DOI":"10.1016\/j.wneu.2010.12.006"},{"key":"4352_CR55","doi-asserted-by":"publisher","unstructured":"Linskey ME, Andrews DW, Asher AL et al (2010) The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96(1). https:\/\/doi.org\/10.1007\/s11060-009-0073-4","DOI":"10.1007\/s11060-009-0073-4"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04352-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04352-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04352-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T04:07:20Z","timestamp":1688530040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04352-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["4352"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04352-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"29 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}